As of April 2024 Pacific Biosciences has a market cap of $0.36 Billion. This makes Pacific Biosciences the world's 6322th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.36 B | -86.11% |
2023 | $2.62 B | 41.85% |
2022 | $1.84 B | -59.02% |
2021 | $4.51 B | -7.07% |
2020 | $4.85 B | 517.07% |
2019 | $0.78 B | -29.21% |
2018 | $1.11 B | 262.27% |
2017 | $0.30 B | -12.83% |
2016 | $0.35 B | -66.48% |
2015 | $1.05 B | 81.19% |
2014 | $0.57 B | 67.21% |
2013 | $0.34 B | 262.99% |
2012 | $95.48 M | -37.78% |
2011 | $0.15 B | -81.75% |
2010 | $0.84 B |
On Apr 24th, 2024 the market cap of Pacific Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $220.39 B | 60,379.95% | ๐บ๐ธ USA |
General Electric GE | $178.00 B | 48,746.72% | ๐บ๐ธ USA |
Illumina ILMN | $19.56 B | 5,269.61% | ๐บ๐ธ USA |
PerkinElmer
PKI | $14.45 B | 3,866.86% | ๐บ๐ธ USA |
Luminex LMNX | $1.75 B | 380.26% | ๐บ๐ธ USA |
NanoString Technologies NSTG | $5.06 M | -98.61% | ๐บ๐ธ USA |